Analysed ABBVIE INC (ABBV:NYSE) News Sources
AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
29-05-2026
yahoo.com
VYM Climbs 26% In a Year While Its Core Dividend Payers Extend Their Streaks
29-05-2026
247wallst.com
What is the current price of ABBVIE INC (ABBV:NYSE)?
The current price of ABBVIE INC (ABBV:NYSE) is $217.72.
ABBVIE INC (ABBV:NYSE) absolute price change since previous trading day?
The absolute price change of ABBVIE INC (ABBV:NYSE) since the previous trading day is $-0.91.
ABBVIE INC (ABBV:NYSE) percentage price change since previous trading day?
The percentage price change of ABBVIE INC (ABBV:NYSE) since the previous trading day is -0.4162%.
What is the most recent average sentiment score for ABBVIE INC (ABBV:NYSE)?
The most recent average sentiment score for ABBVIE INC (ABBV:NYSE) is 81 out of 100.
What is the most recent average sentiment for ABBVIE INC (ABBV:NYSE)?
The most recent sentiment for ABBVIE INC (ABBV:NYSE) is .
SEC-8K** Filing Available For ABBVIE INC (ABBV:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.